1. |
- Buric, Filip, 1988, et al.
(author)
-
Parallel Factor Analysis Enables Quantification and Identification of Highly Convolved Data-Independent-Acquired Protein Spectra
- 2020
-
In: Patterns. - : Elsevier BV. - 2666-3899. ; 1:9
-
Journal article (peer-reviewed)abstract
- The latest high-throughput mass spectrometry-based technologies can record virtually all molecules from complex biological samples, providing a holistic picture of proteomes in cells and tissues and enabling an evaluation of the overall status of a person's health. However, current best practices are still only scratching the surface of the wealth of available information obtained from the massive proteome datasets, and efficient novel data-driven strategies are needed. Powered by advances in GPU hardware and open-source machine-learning frameworks, we developed a data-driven approach, CANDIA, which disassembles highly complex proteomics data into the elementary molecular signatures of the proteins in biological samples. Our work provides a performant and adaptable solution that complements existing mass spectrometry techniques. As the central mathematical methods are generic, other scientific fields that are dealing with highly convolved datasets will benefit from this work.
|
|
2. |
- Messner, Christoph B., et al.
(author)
-
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
- 2020
-
In: Cell Systems. - : Elsevier BV. - 2405-4712 .- 2405-4720. ; 11:1, s. 11-24.E4
-
Journal article (peer-reviewed)abstract
- The COVID-19 pandemic is an unprecedented global challenge, and point-of-care diagnostic classifiers are urgently required. Here, we present a platform for ultra-high-throughput serum and plasma proteomics that builds on ISO13485 standardization to facilitate simple implementation in regulated clinical laboratories. Our low-cost workflow handles up to 180 samples per day, enables high precision quantification, and reduces batch effects for large-scale and longitudinal studies. We use our platform on samples collected from a cohort of early hospitalized cases of the SARS-CoV-2 pandemic and identify 27 potential biomarkers that are differentially expressed depending on the WHO severity grade of COVID-19. They include complement factors, the coagulation system, inflammation modulators, and pro-inflammatory factors upstream and downstream of interleukin 6. All protocols and software for implementing our approach are freely available. In total, this work supports the development of routine proteomic assays to aid clinical decision making and generate hypotheses about potential COVID-19 therapeutic targets.
|
|
3. |
- Zrimec, Jan, 1981, et al.
(author)
-
Deep learning suggests that gene expression is encoded in all parts of a co-evolving interacting gene regulatory structure
- 2020
-
In: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 11:1
-
Journal article (peer-reviewed)abstract
- Understanding the genetic regulatory code governing gene expression is an important challenge in molecular biology. However, how individual coding and non-coding regions of the gene regulatory structure interact and contribute to mRNA expression levels remains unclear. Here we apply deep learning on over 20,000 mRNA datasets to examine the genetic regulatory code controlling mRNA abundance in 7 model organisms ranging from bacteria to Human. In all organisms, we can predict mRNA abundance directly from DNA sequence, with up to 82% of the variation of transcript levels encoded in the gene regulatory structure. By searching for DNA regulatory motifs across the gene regulatory structure, we discover that motif interactions could explain the whole dynamic range of mRNA levels. Co-evolution across coding and non-coding regions suggests that it is not single motifs or regions, but the entire gene regulatory structure and specific combination of regulatory elements that define gene expression levels. Regulatory and coding regions of genes are shaped by evolution to control expression levels. Here, the authors use deep learning to identify rules controlling gene expression levels and suggest that all parts of the gene regulatory structure interact in this.
|
|